PA

Perceptive Advisors Portfolio holdings

AUM $5.46B
1-Year Est. Return 264.28%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+264.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.52B
AUM Growth
-$1.75B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
173
New
Increased
Reduced
Closed

Top Buys

1
+$194M
2
+$68.7M
3
+$68.4M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$62.1M
5
SWTX
SpringWorks Therapeutics
SWTX
+$52.6M

Top Sells

1
+$116M
2
+$100M
3
+$90.4M
4
NVTA
Invitae Corporation
NVTA
+$87.4M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$87.3M

Sector Composition

1 Healthcare 84.16%
2 Financials 0.49%
3 Industrials 0.21%
4 Consumer Discretionary 0.02%
5 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
151
– –
-1,043,000
152
– –
0
153
– –
-97,500
154
– –
-224,224
155
– –
-440,000
156
– –
-2,400,000
157
– –
-300,000
158
– –
-2,500,000
159
– –
0
160
– –
-337,800
161
– –
-3,333,332
162
– –
-27,455
163
– –
-40,000
164
– –
-420,875
165
– –
-1,000,000
166
– –
-3,116,831
167
– –
-700,000
168
– –
-686,922
169
– –
-203,591
170
– –
-55,175
3 4 5 6
7